Role of RPL39 in Metaplastic Breast Cancer

Bhuvanesh Dave, Daniel Davila Gonzalez, Zhi-Bin Liu, Xiaoxian Li, Helen Wong, Sergio Granados‐Principal, Nadeer E. Ezzedine, Douglas H. Sieglaff, Joe Ensor, Kathy D. Miller,

JNCI Journal of the National Cancer Institute · 2016 · 76 citations · 29 references

DOIFull text

Open access

Abstract

NOS inhibitors and RNA editing modulators may offer novel treatment options for metaplastic breast cancer.

References

29